Skip to content

Antitetanus Vaccination for People Older Than 65 Years.

Antitetanus Vaccination for People Older Than 65 Years in the Auvergne-Rhône-Alpes (France) Region Depending on the Demographic and Medical Practice of Their Medical Practitioner.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03266211
Acronym
VAT65
Enrollment
261
Registered
2017-08-30
Start date
2017-11-09
Completion date
2017-12-23
Last updated
2018-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tetanus

Brief summary

In the last ten years, more than one hundred generalized tetanus cases were declared in France. Most of them were affecting people older than 70 years with an important mortality (around 28%). It is know that the only way to protect ourselves from this disease is the vaccination. In France tetanus vaccination is mandatory since 1940. Nowaday none study looked specifically for the vaccination of people older than 65 years. The hypothesis is: there is a difference in the tetanus vaccination coverage for people older than 65 years depending on the demographic and medical practice of their general practitioner.

Interventions

Patient will have to answer a quiz which is about their vaccination against tetanus.

OTHERQuestionnaire General practitioner

General practitioner will have to answer a quiz which is about their medical practice concerning vaccination against tetanus.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients older than 65 years consulting their attending physician in and who agreed to participate in the study. * The doctors included are general practitioners located in a liberal office in the Auvergne Rhône Alpes region for which the URPS (Union régional des Professionnels de Santé) has an email address.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Tetanus vaccination coverageAbout 5 minutesPatient will have to answer a quiz which is about their vaccination against tetanus.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026